{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["idiopathic granulomatous mastitis", "ozone therapy", "refractory granulomatous mastitis", "steroid", "steroid resistance"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "37484853", "DateRevised": {"Year": "2023", "Month": "12", "Day": "27"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2023", "Month": "07", "Day": "06"}], "ELocationID": ["1174372", "10.3389/fmed.2023.1174372"], "Journal": {"ISSN": "2296-858X", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2023"}}, "Title": "Frontiers in medicine", "ISOAbbreviation": "Front Med (Lausanne)"}, "ArticleTitle": "Ozone therapy as a novel complementary therapeutic approach in refractory idiopathic granulomatous mastitis.", "Pagination": {"StartPage": "1174372", "MedlinePgn": "1174372"}, "Abstract": {"AbstractText": ["Autoimmunity may play a major role in the pathogenesis of idiopathic granulomatous mastitis (IGM). The therapeutic potential of ozone therapy has recently been shown in rheumatological diseases, and this study aimed to assess the clinical efficacy of ozone therapy (OT) in refractory IGM.", "Patients with biopsy-verified IGM and incomplete response after steroid therapy (<i>n</i>\u2009=\u200947) between 2018 and 2021 were enrolled. Of these, 23 cases in cohort A had standard treatment with further steroid therapy (ST), and 24 were treated with systemic OT via autohemotherapy (AHT) in addition to steroid therapy (cohort B).", "The median age was 33 years (range, 24-45). Patients in cohort B had a higher complete response rate after completion of a four-month ozone therapy than those in the ST-group (OT-group, 37.5% vs. ST-group, 0%; <i>p</i>\u2009=\u20090.002). At a median follow-up of 12 months (range, 12-35), the patients treated with OT had a lower one-year recurrence in the affected breast than cases in cohort A treated with ST (OT-group, 21% vs. ST-group, 70%; <i>p</i>\u2009=\u20090.001). No significant side effects were observed in patients in cohort B related to AHT. Furthermore, OT significantly decreased the total steroid treatment duration (median week of steroid use; 26 \u2009weeks in cohort A vs. 12 weeks in cohort B; <i>p</i>\u2009=\u20090.001).", "Systemic OT increases the complete response rate and decreases the duration of steroid treatment in patients with refractory IGM. Therefore, ozone therapy is an effective, well-tolerated, and safe novel complementary therapeutic modality."], "CopyrightInformation": "Copyright \u00a9 2023 Cabioglu, Trabulus, Emiroglu, Ozkurt, Yalcin, Dinc, Tukenmez, Muslumanoglu, Igci, Ozmen, Dinccag and Guven."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Istanbul Faculty of Medicine, Department of Surgery, Istanbul University, Istanbul, T\u00fcrkiye."}], "LastName": "Cabioglu", "ForeName": "Neslihan", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgery, Bahcesehir University, Istanbul, T\u00fcrkiye."}], "LastName": "Trabulus", "ForeName": "Didem Can", "Initials": "DC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Istanbul Faculty of Medicine, Department of Surgery, Istanbul University, Istanbul, T\u00fcrkiye."}], "LastName": "Emiroglu", "ForeName": "Selman", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgery, Istanbul Florence Nightingale Hospital, Istanbul, T\u00fcrkiye."}], "LastName": "Ozkurt", "ForeName": "Enver", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Istanbul Faculty of Medicine, Department of Surgery, Istanbul University, Istanbul, T\u00fcrkiye."}], "LastName": "Yalcin", "ForeName": "Nesli", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Istanbul Faculty of Medicine, Department of Surgery, Istanbul University, Istanbul, T\u00fcrkiye."}], "LastName": "Dinc", "ForeName": "Nagehan", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Istanbul Faculty of Medicine, Department of Surgery, Istanbul University, Istanbul, T\u00fcrkiye."}], "LastName": "Tukenmez", "ForeName": "Mustafa", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Istanbul Faculty of Medicine, Department of Surgery, Istanbul University, Istanbul, T\u00fcrkiye."}], "LastName": "Muslumanoglu", "ForeName": "Mahmut", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgery, American Hospital, Istanbul, T\u00fcrkiye."}], "LastName": "Igci", "ForeName": "Abdullah", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgery, Istanbul Florence Nightingale Hospital, Istanbul, T\u00fcrkiye."}], "LastName": "Ozmen", "ForeName": "Vahit", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Istanbul Faculty of Medicine, Department of Surgery, Istanbul University, Istanbul, T\u00fcrkiye."}], "LastName": "Dinccag", "ForeName": "Ahmet Sait", "Initials": "AS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Continuing Medical Education, Medipol University, Istanbul, T\u00fcrkiye."}], "LastName": "Guven", "ForeName": "Yusuf Izzettin", "Initials": "YI"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Med (Lausanne)", "NlmUniqueID": "101648047", "ISSNLinking": "2296-858X"}, "CommentsCorrectionsList": [{"RefSource": "Front Med (Lausanne). 2023 Dec 11;10:1272059. doi: 10.3389/fmed.2023.1272059", "PMID": "38148915"}], "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Kessler E, Wolloch Y. Granulomatous mastitis: a lesion clinically simulating carcinoma. Am J Clin Pathol. (1972) 58:642\u20136. doi: 10.1093/ajcp/58.6.642, PMID:", "ArticleIdList": ["10.1093/ajcp/58.6.642", "4674439"]}, {"Citation": "Wolfrum A, K\u00fcmmel S, Theierkauf I, Pelz E, Reinisch E. Granulomatous mastitis: a therapeutic and diagnostic challenge. Breast Care. (2018) 13:413\u20138. doi: 10.1159/000495146", "ArticleIdList": ["10.1159/000495146", "PMC6381909", "30800035"]}, {"Citation": "Parperis K, Achilleos S, Costi E, Vardas M. Autoimmune rheumatic diseases associated with granulomatous mastitis. Rheumatol Int. (2023) 43:399\u2013407. doi: 10.1007/s00296-022-05251-9, PMID:", "ArticleIdList": ["10.1007/s00296-022-05251-9", "36418558"]}, {"Citation": "Koksal H. The clinical utility of autoantibodies in patients with idiopathic granulomatous mastitis. J Surg Invest. (2020) 35:325\u20139. doi: 10.1080/08941939.2020.1861666, PMID:", "ArticleIdList": ["10.1080/08941939.2020.1861666", "33327830"]}, {"Citation": "Ucaryilmaz H, Koksal H, Emsen A, Kadoglou N, Dixon JM, Artac H. The role of regulatory T and B cells in the etiopathogenesis of idiopathic granulomatous mastitis. Immunol Invest. (2022) 51:357\u201367. doi: 10.1080/08820139.2020.1832114", "ArticleIdList": ["10.1080/08820139.2020.1832114", "33034215"]}, {"Citation": "Koksal H, Vatansev H, Artac H, Kad\u0131oglou N. The clinical value of interleukins-8, \u221210, and-17 in idiopathic granulomatous mastitis. Clin Rheumatol. (2020) 39:1671\u20137. doi: 10.1007/s10067-020-04925-8, PMID:", "ArticleIdList": ["10.1007/s10067-020-04925-8", "31916110"]}, {"Citation": "Erozgen F, Ersoy YE, Akaydin M, Memmi N, Celik AS, Celebi F, et al. . Corticosteroid treatment and timing of surgery in idiopathic granulomatous mastitis confusing with breast carcinoma. Breast Cancer Res Treat. (2010) 123:447\u201352. doi: 10.1007/s10549-010-1041-6", "ArticleIdList": ["10.1007/s10549-010-1041-6", "20625813"]}, {"Citation": "Mizrakli T, Velidedeoglu M, Yemisen M, Mete B, Kilic F, Yilmaz H, et al. . Corticosteroid treatment in the management of idiopathic granulomatous mastitis to avoid unnecessary surgery. Surg Today. (2015) 45:457\u201365. doi: 10.1007/s00595-014-0966-5, PMID:", "ArticleIdList": ["10.1007/s00595-014-0966-5", "24993812"]}, {"Citation": "Asoglu O, Ozmen V, Karanlik H, Tunaci M, Cabioglu N, Igci A, et al. . Feasibility of surgical management in patients with granulomatous mastitis. Breast J. (2005) 11:108\u201314. doi: 10.1111/j.1075-122X.2005.21576.x, PMID:", "ArticleIdList": ["10.1111/j.1075-122X.2005.21576.x", "15730456"]}, {"Citation": "Basim P, Argun D, Argun F. Risk factors for idiopathic granulomatous mastitis recurrence after patient-tailored treatment: do we need an escalating treatment algorithm? Breast Care (Basel). (2022) 17:172\u20139. doi: 10.1159/000517399, PMID:", "ArticleIdList": ["10.1159/000517399", "PMC9149487", "35707181"]}, {"Citation": "Zhang C, Lei S, Kong C, Tan Y, Dai X, He J, et al. . Clinical study on surgical treatment of granulomatous lobular mastitis. Gland Surg. (2019) 8:712\u201322. doi: 10.21037/gs.2019.11.12, PMID:", "ArticleIdList": ["10.21037/gs.2019.11.12", "PMC6989911", "32042679"]}, {"Citation": "Karanlik H, Ozgur \u0130, Simsek \u015e, Fathalizadeh A, Tukenmez M, Sahin D, et al. . Can steroids plus surgery become a first-line treatment of idiopathic granulomatous mastitis? Breast Care (Basel). (2014) 9:338\u201342. doi: 10.1159/000366437, PMID:", "ArticleIdList": ["10.1159/000366437", "PMC4322692", "25759614"]}, {"Citation": "Akcan A, Oz AB, Dogan S, Akg\u00fcn H, Aky\u00fcz M, Ok E, et al. . Idiopathic granulomatous mastitis: comparison of wide local excision with or without corticosteroid therapy. Breast Care (Basel). (2014) 9:111\u20135. doi: 10.1159/000360926, PMID:", "ArticleIdList": ["10.1159/000360926", "PMC4038310", "24944554"]}, {"Citation": "\u00c7etin K, S\u0131kar HE, G\u00f6ret NE, Rona G, Bar\u0131\u015f\u0131k N\u00d6, K\u00fc\u00e7\u00fck HF, et al. . Comparison of topical, systemic, and combined therapy with steroids on idiopathic granulomatous mastitis: a prospective randomized study. World J Surg. (2019) 43:2865\u201373. doi: 10.1007/s00268-019-05084-x, PMID:", "ArticleIdList": ["10.1007/s00268-019-05084-x", "31297582"]}, {"Citation": "Lei X, Chen K, Zhu L, Song E, Su F, Li S. Treatments for idiopathic granulomatous mastitis: systematic review and Meta-analysis. Breastfeed Med. (2017) 12:415\u201321. doi: 10.1089/bfm.2017.0030, PMID:", "ArticleIdList": ["10.1089/bfm.2017.0030", "28731822"]}, {"Citation": "Ma X, Min X, Yao C. Different treatments for granulomatous lobular mastitis: a systematic review and Meta-analysis. Breast Care (Basel). (2020) 15:60\u20136. doi: 10.1159/000501498, PMID:", "ArticleIdList": ["10.1159/000501498", "PMC7098302", "32231499"]}, {"Citation": "Wen Q, Liu D, Wang X, Zhang Y, Fang S, Qiu X, et al. . A systematic review of ozone therapy for treating chronically refractory wounds and ulcers. Int Wound J. (2022) 19:853\u201370. doi: 10.1111/iwj.13687, PMID:", "ArticleIdList": ["10.1111/iwj.13687", "PMC9013593", "34612569"]}, {"Citation": "Wen Q, Liu D, Wang X, Zhang Y, Fang S, Qiu X, et al. . Effects of ozone for treating chronically refractory wounds and ulcers: a protocol for systematic review and meta-analysis of randomized clinical trials. Medicine (Baltimore). (2020) 99:e20457. doi: 10.1097/MD.0000000000020457, PMID:", "ArticleIdList": ["10.1097/MD.0000000000020457", "32481453"]}, {"Citation": "Zhang J, Guan M, Xie C, Luo X, Zhang Q, Xue Y. Increased growth factors play a role in wound healing promoted by noninvasive oxygen-ozone therapy in diabetic patients with foot ulcers. Oxidative Med Cell Longev. (2014) 2014:273475. doi: 10.1155/2014/273475", "ArticleIdList": ["10.1155/2014/273475", "PMC4096389", "25089169"]}, {"Citation": "Dhamnaskar S, Gobbur N, Koranne M, Vasa D. Prospective comparative observational study of safety and efficacy of topical Ozone gas therapy in healing of diabetic foot ulcers versus only conventional wound management. Surg J (N Y). (2021) 7:e226\u201336. doi: 10.1055/s-0041-1731447, PMID:", "ArticleIdList": ["10.1055/s-0041-1731447", "PMC8440051", "34541314"]}, {"Citation": "Pchepiorka R, Moreira MS, Lascane NADS, Catalani LH, Allegrini S, Jr, de Lima NB, et al. . Effect of ozone therapy on wound healing in the buccal mucosa of rats. Arch Oral Biol. (2020) 119:104889. doi: 10.1016/j.archoralbio.2020.104889, PMID:", "ArticleIdList": ["10.1016/j.archoralbio.2020.104889", "32911119"]}, {"Citation": "Aslaner A, \u00c7ak\u0131r T, Tekeli S\u00d6, Avc\u0131 S, Do\u011fan U, Tekeli F, et al. . Medical ozone treatment ameliorates the acute distal colitis in rat. Acta Cir Bras. (2016) 31:256\u201363. doi: 10.1590/S0102-865020160040000006", "ArticleIdList": ["10.1590/S0102-865020160040000006", "27168538"]}, {"Citation": "Vaillant JD, Fraga A, Diaz MT, Mallok A, Viebahn-H\u00e4nsler R, Fahmy Z, et al. . Ozone oxidative postconditioning ameliorates joint damage and decreases pro-inflammatory cytokine levels and oxidative stress in PG/PS-induced arthritis in rats. Eur J Pharmocol. (2013) 714:318\u201324. doi: 10.1016/j.ejphar.2013.07.034, PMID:", "ArticleIdList": ["10.1016/j.ejphar.2013.07.034", "23911887"]}, {"Citation": "Fern\u00e1ndez OSL, Viebahn-Haensler R, Cabreja GL, Espinosa IS, Matos YH, Roche LD, et al. . Medical ozone increases methotrexate clinical response and improves cellular redox balance in patients with rheumatoid arthritis. Eur J Pharmacol. (2016) 789:313\u20138. doi: 10.1016/j.ejphar.2016.07.031, PMID:", "ArticleIdList": ["10.1016/j.ejphar.2016.07.031", "27450487"]}, {"Citation": "Bocci V. (Ed.). The clinical application of Ozone therapy In: 1.1.5. Autoimmune diseases. Can Ozone therapy do better than antibodies to TNF-\u03b1? A new medical drug. Berlin: Springer; (2005). 149\u201361."}, {"Citation": "Ogata A, Nagahata H. Intra-mammary application of ozone therapy to acute clinical mastitis in dairy cows. J Vet Med Sci. (2000) 62:681\u20136. doi: 10.1292/jvms.62.681", "ArticleIdList": ["10.1292/jvms.62.681", "10945283"]}, {"Citation": "Ohtsuka H, Ogata A, Terasaki N, Koiwa M, Kawamura S. Changes in leukocyte population after ozonated autohemoadministration in cows with inflammatory diseases. J Vet Med Sci. (2006) 68:175\u20138. doi: 10.1292/jvms.68.175, PMID:", "ArticleIdList": ["10.1292/jvms.68.175", "16520542"]}, {"Citation": "Drucic D, Valpotic H, Samardzija M. Prophylaxis and therapeutic potential of ozone in buiatrics: current knowledge. Anim Prod Sci. (2015) 159:1\u20137. doi: 10.1016/j.anireprosci.2015.05.017", "ArticleIdList": ["10.1016/j.anireprosci.2015.05.017", "26059777"]}, {"Citation": "Samard\u017eija M, Turk R, Sobiech P, Valpoti\u0107 H, Harapin I, Gra\u010dner D, et al. . Intrauterine ozone treatment of puerperal disorders in domestic ruminants: a review. Vet Arhiv. (2017) 87:363\u201375. doi: 10.24099/vet.arhiv.160119a", "ArticleIdList": ["10.24099/vet.arhiv.160119a"]}, {"Citation": "Cabioglu N, Aktas EC, Emiroglu S, Tukenmez M, Ozkurt E, Muslumanoglu M. Ozone therapy restores immune dysfunction in refractory idiopathic granulomatous mastitis as a novel potential therapeutic approach. Cell Biol Int. (2023) 47:228\u201337. doi: 10.1002/cbin.11953, PMID:", "ArticleIdList": ["10.1002/cbin.11953", "36378588"]}, {"Citation": "Viebahn-Haensler R, Le\u00f3n Fern\u00e1ndez OS, Fahmy Z. Ozone in medicine: the low-dose ozone concept. Guidelines and treatment strategies. Ozone Sci Eng. (2012) 34:408\u201324. doi: 10.1080/01919512.2012.717847", "ArticleIdList": ["10.1080/01919512.2012.717847"]}, {"Citation": "Viebahn-Haensler R, Fern\u00e1ndez OSL. Ozone in medicine: the low-dose ozone concept and its basic biochemical mechanisms of action in chronic inflammatory diseases. Int J Mol Sci. (2021) 22:7890. doi: 10.3390/ijms22157890, PMID:", "ArticleIdList": ["10.3390/ijms22157890", "PMC8346137", "34360655"]}, {"Citation": "Bocci V. (Ed.). How is Ozone administered? In: Ozone a new medical Drug. Berlin: Springer; (2005). 29\u201336."}, {"Citation": "Bocci V. (Ed.). The actual six therapeutic modalitites In: Ozone a new medical drug. Berlin: Springer; (2005). 37\u201374."}, {"Citation": "Baeza J, Cabo JR, Gomez M, Menendez S, Re L. WFOTs reviews on evidence based ozone therapy. Bucharest: World Federation of Ozone Therapy; (2015)."}, {"Citation": "Madrid Declaration on Ozone Therapy . (2020). Available at: https://isco3.org/producto/madrid-declaration-on-ozone-therapy-3rd-edition-online-access-english/ (Accessed 2020 March 22, 2020)."}, {"Citation": "Bocci V. (Ed.). The clinical application of Ozone therapy In: Ozone a new medical drug. Berlin: Springer; (2005). 97\u2013226."}, {"Citation": "Kundaktepe BP, Velidedeoglu M, Mete B. The effect of methotrexate monotherapy on treatment-resistant idiopathic granulomatous mastitis patients. Surgeon. (2021) 20:e13\u20139. doi: 10.1016/j.surge.2021.03.001, PMID:", "ArticleIdList": ["10.1016/j.surge.2021.03.001", "33836950"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "4", "Day": "3"}, {"Year": "2023", "Month": "6", "Day": "16"}, {"Year": "2023", "Month": "7", "Day": "24", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "7", "Day": "24", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "7", "Day": "24", "Hour": "4", "Minute": "49"}, {"Year": "2023", "Month": "7", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["37484853", "PMC10357005", "10.3389/fmed.2023.1174372"]}}], "PubmedBookArticle": []}